C254H297N45O16 — CID 158115257
(2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide (PubChem CID 158115257) has the molecular formula C254H297N45O16 and a molecular weight of 4236.47 g/mol. Its IUPAC name is (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide.
| Compound Name | (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide |
|---|---|
| PubChem CID | 158115257 |
| Molecular Formula | C254H297N45O16 |
| Molecular Weight | 4236.47 g/mol |
| Exact Mass | 4233.38 |
| IUPAC Name | (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide |
| SMILES | CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)cn2)c2ccccc2)cc1 |
| InChI | InChI=1S/6C29H35N5O2.C28H33N5O2.2C26H27N5O/c6*1-4-33-16-17-34(20-27(33)35)25-14-15-26(30-19-25)32-29(36)28(24-8-6-5-7-9-24)31-18-22(3)23-12-10-21(2)11-13-23;1-20-9-11-22(12-10-20)21(2)17-30-27(23-7-5-4-6-8-23)28(35)31-25-14-13-24(18-29-25)33-16-15-32(3)26(34)19-33;2*1-18-8-10-20(11-9-18)19(2)14-28-25(21-6-4-3-5-7-21)26(32)31-24-13-12-22(15-27-24)23-16-29-30-17-23/h6*5-15,19,22,28,31H,4,16-18,20H2,1-3H3,(H,30,32,36);4-14,18,21,27,30H,15-17,19H2,1-3H3,(H,29,31,35);2*3-13,15-17,19,25,28H,14H2,1-2H3,(H,29,30)(H,27,31,32)/t3*22-,28+;3*22-,28-;21-,27+;2*19-,25-/m110110110/s1 |
| InChIKey | FQXQAJMTCGJRCJ-YLEGHXTMSA-N |
| XLogP | 38.24 |
| TPSA | 708.39 Ų |
| H-Bond Donors | 20 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 78 |
| Heavy Atoms | 315 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4236.47 |
| LogP ≤ 5 | 38.24 |
| H-Bond Donors ≤ 5 | 20 |
| H-Bond Acceptors ≤ 10 | 43 |